ApprovalTrail

Approval · Notice of Compliance 8296 · 2006

ACYCLOVIR: Notice of Compliance 8296

Issued October 2, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
8296
Date
October 2, 2006
Company
Genpharm Inc.Etobicoke, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
Additional product name
Therapeutic class
Antiviral agent
Canadian reference product
ZOVIRAX (Glaxo Wellcome Inc.)

Products in this notice

BrandDINStatus today
ACYCLOVIR02286556Cancelled Post Market
ACYCLOVIR02286564Cancelled Post Market
ACYCLOVIR02286572Cancelled Post Market

Medicinal ingredients